The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
09-Nov-09
$327 million
Target:
Enzon Pharmaceuticals, Inc.
Acquiror:
Sigma-Tau Pharmaceuticals
Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company
06-Jul-09
$2.0 billion
Target:
PARIS RE Holdings Ltd.
Acquiror:
PartnerRe Ltd.
Advised PartnerRe Ltd., a leading global reinsurer, providing multi-line reinsurance to insurance companies, on its acquisition of PARIS RE Holdings Ltd., a French-listed, Swiss-based diversified reinsurer
18-May-09
$114 million
Target:
Close Brothers Corporate Finance Holdings Ltd.
Acquiror:
Daiwa Securities SMBC Europe Ltd.
Advised Close Brothers Group plc, an independent financial services group, on the sale of its corporate finance subsidiary to Daiwa Securities SMBC Europe Ltd.
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
12-Oct-08
$6.0 billion
Target:
Hapag-Lloyd AG
Acquiror:
Albert Ballin KG
Advised TUI AG, Europe’s largest tourism company, on its sale of its shipping division Hapag-Lloyd AG, one of the leading global container shipping companies
08-Oct-08
$NA
Target:
MAN Ferrostaal AG
Acquiror:
International Petroleum Investment Company (IPIC)
Advised MAN AG in relation to its 70% sale of MAN Ferrostaal AG, a worldwide supplier of industrial services for the construction of large-scale industrial plants and machine supply, to International Petroleum Investment Company (IPIC)
01-Oct-08
$53 million
Target:
Biotage (Biosystems division)
Acquiror:
Qiagen NV
Advised Biotage AB (OMX: BIOT), a global biotechnology company, on its strategic review resulting in the disposal of its Biosystems division which offers systems for genetic analysis mainly for use in clinical research
02-Jul-08
$NA
Target:
NewSmith Capital
Acquiror:
UniCredit SpA
Advised NewSmith Capital, an independent investment management group, on a strategic agreement with UniCredit whereby UniCredit will acquire NewSmith’s Financial Products credit advisory business, assume a 5% stake in NewSmith Capital and become an investor in NewSmith funds
22-Jan-08
$3.4 billion
Target:
Ventana Medical Systems, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
02-Oct-07
$4.6 billion
Target:
Nikko Cordial Corporation
Acquiror:
Citigroup, Inc.
Advised Nikko Cordial, one of Japan’s largest securities firms, on its share exchange with Citigroup Inc., which resulted in Citigroup’s acquisition of the remaining 32% of Nikko Cordial that it did not already own
31-Jul-07
$491 million
Target:
DEUTZ Power Systems
Acquiror:
3i
Sole advisor to DEUTZ AG on the divestiture of its division DEUTZ Power Systems, a leading manufacturer of gas fired engines for decentralized power generation
18-Jul-07
$NA
Target:
SF-Chem AG
Acquiror:
CABB GmbH
Sole advisor to CABB, a leading producer of monochloroacetic acid and related specialty intermediates, on the acquisition of SF-Chem, a manufacturer of chlorine and sulphur specialty intermediates
29-May-07
$99.1 billion
Target:
ABN AMRO Holding NV
Acquiror:
Fortis SA/NV, The Royal Bank of Scotland Group plc, Banco Santander Central Hispano, SA
Advised Fortis on an offer by Fortis, RBS and Santander for ABN AMRO
20-Dec-06
$424 million
Target:
Aton Capital
Acquiror:
Bank Austria Creditanstalt / UniCredit Group
Advised Aton Capital Group, the independent Russian investment bank, on the sale of its Institutional Business to Bank Austria Creditanstalt (part of the UniCredit Group)
24-Mar-06
$21.2 billion
Target:
Schering AG
Acquiror:
Bayer AG
Advised Bayer on its public offer for Schering, an international pharmaceuticals group based in Berlin, Germany
20-Feb-06
$254 million
Target:
Textile Effects
Acquiror:
Huntsman Corporation
(division of Ciba Specialty Chemicals AG)
Advised Ciba Specialty Chemicals AG on the sale of its global Textile Effects business
28-Nov-05
$103 million
Target:
Akzo Nobel N.V.
Acquiror:
Hexion Specialty Chemicals Inc.
(Ink and Adhesive Resins business) Advised Akzo Nobel N.V., a global leader in coatings, chemicals and healthcare on the sale of its Ink and Adhesive Resins business to Hexion Specialty Chemicals Inc
25-Oct-05
$2.1 billion
Target:
BHW Holding AG
Acquiror:
Deutsche Postbank AG
Advised BHW Holding AG, a retail financial services group, in connection with its sale to Deutsche Postbank AG, Germany’s largest retail bank
20-Oct-05
$NA
Target:
Drakkar Holdings SA (Adisseo Group)
Acquiror:
China National Chemical Corporation
Advised CVC Capital Partners on the divestiture of Adisseo via the sale of Drakkar Holdings SA to China National BlueStar, a subsidiary of state-owned diversified chemicals company China National Chemical Corporation. Adisseo is a leading player in the animal nutrition market
22-Jun-05
$198 million
Target:
Rothschilds Continuation Holdings
Acquiror:
Jardine Strategic Holdings
held by Royal & Sun Alliance
Advised Royal & Sun Alliance on the sale of its 21.5% shareholding in Rothschilds Continuation Holdings AG to Jardine Strategic Holdings
15-Oct-04
$135 million
Target:
Akzo Nobel N.V.
Acquiror:
Nuplex Industries Ltd.
Advised Akzo Nobel N.V., a global leader in coatings, chemicals and pharmaceuticals, on the sale of its coating resins activities to Nuplex Industries Ltd.
22-Sep-00
$750 million
Target:
AerFi Group plc
Acquiror:
debis AirFinance (subsidiary of Daimler Chrysler AG)
Advised AerFi on its sale to debis AirFinance .